Gateway Distriparks Ltd, Bikaji Foods International Ltd, PNB Housing Finance Ltd and DCB Bank Ltd are among the other gainers in the BSE's 'A' group today, 25 October 2024.Laurus Labs Ltd soared 7.11% to Rs 477.7 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 2.07 lakh shares were traded on the counter so far as against the average daily volumes of 51251 shares in the past one month. Gateway Distriparks Ltd surged 5.64% to Rs 87.11. The stock was the second biggest gainer in 'A' group. On the BSE, 4.81 lakh shares were traded on the counter so far as against the average daily volumes of 61210 shares in the past one month. Bikaji Foods International Ltd spiked 4.37% to Rs 872.4. The stock was the third biggest gainer in 'A' group. On the BSE, 1.11 lakh shares were traded on the counter so far as against the average daily volumes of 32035 shares in the past one month. PNB Housing Finance Ltd advanced 4.16% to Rs 972.1. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.42 lakh shares were traded on the counter so far as against the average daily volumes of 54275 shares in the past one month. DCB Bank Ltd gained 3.85% to Rs 114.5. The stock was the fifth biggest gainer in 'A' group. On the BSE, 6.82 lakh shares were traded on the counter so far as against the average daily volumes of 1.11 lakh shares in the past one month. Powered by Capital Market - Live

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 24 October 2024, inter alia, have recommended the interim dividend of Rs 0.4 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Laurus Labs declined 46.31% to Rs 19.84 crore in the quarter ended September 2024 as against Rs 36.95 crore during the previous quarter ended September 2023. Sales declined 0.06% to Rs 1223.70 crore in the quarter ended September 2024 as against Rs 1224.45 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1223.701224.45 0 OPM %14.5715.34 - PBDT130.32147.26 -12 PBT22.8153.89 -58 NP19.8436.95 -46 Powered by Capital Market - Live

Laurus Labs has fixed 06 November 2024 as record date for interim dividend of Rs 0.40 per share for FY 2024-25. Powered by Capital Market - Live

Laurus Labs will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live

Laurus Labs Ltd gained for a fifth straight session today. The stock is quoting at Rs 478.6, up 0.94% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.69% on the day, quoting at 25137.7. The Sensex is at 82005.67, up 0.77%. Laurus Labs Ltd has slipped around 5.14% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has slipped around 0.37% in last one month and is currently quoting at 23582.25, down 0.2% on the day. The volume in the stock stood at 11.64 lakh shares today, compared to the daily average of 20.53 lakh shares in last one month. The benchmark October futures contract for the stock is quoting at Rs 478.25, up 0.6% on the day. Laurus Labs Ltd is up 20.04% in last one year as compared to a 27.4% spurt in NIFTY and a 55.19% spurt in the Nifty Pharma index.The PE of the stock is 106.77 based on TTM earnings ending June 24.Powered by Capital Market - Live

Laurus Labs Ltd fell for a fifth straight session today. The stock is quoting at Rs 463.95, down 4.42% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.06% on the day, quoting at 25392.05. The Sensex is at 83172.83, up 0.27%.Laurus Labs Ltd has gained around 6.07% in last one month.Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has increased around 2.13% in last one month and is currently quoting at 23025.2, down 0.76% on the day. The volume in the stock stood at 24.45 lakh shares today, compared to the daily average of 26.51 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 465.85, down 3.9% on the day. Laurus Labs Ltd jumped 17.43% in last one year as compared to a 27.59% rally in NIFTY and a 47.81% spurt in the Nifty Pharma index.The PE of the stock is 109.21 based on TTM earnings ending June 24.Powered by Capital Market - Live

Laurus Labs announced the inauguration of its state of the art new R&D center at IKP Knowledge Park, Plot No DS15, Kolthur Shamirpet Medchal Telangana. Key highlights: - Total investment incurred for setting up the new R&D Rs 250 crore - 2,00,000 Square foot facility equipped with modern laboratories and infrastructure - R&D Center to support the CDMO business of Laurus Labs - Will provide job opportunities to over 800 peoplePowered by Capital Market - Live

The pharmaceutical company said that its API manufacturing facility located at Hyderabad has completed the United States Food and Drug Administration (USFDA) inspection without any 483 observation. The USFDA conducted the inspection from 9 September 2024 to 13 September 2024. Laurus Labs' API manufacturing facility, located at DS-1, IKP Knowledge Park, Genome Valley, Shameerpet, Telangana is instrumental in developing active pharmaceutical ingredients, bolstering the company's ability to deliver high-quality, innovative pharmaceutical solutions to its global customers. Laurus Labs is a fully integrated pharmaceutical and biotechnology company, with a leadership position in generic active pharmaceutical ingredients (APIs) and a major focus on anti-retroviral, oncology drugs, cardiovascular, gastro and hepatitis C therapeutics. The company also develops and manufactures oral solid formulations, provide contract research and manufacturing services (CRAMS) to global pharma companies. The company's consolidated net profit dropped 49.7% to Rs 12.51 crore in Q1 FY24 as against Rs 24.85 crore reported in Q1 FY24. Net sales was at Rs 1,194.91 crore in Q1 FY25, up 1.1% from Rs 1,181.79 crore recorded in the same period a year ago. Shares of Laurus Labs shed 0.25% to settle at Rs 505.70 on Friday, 13 September 2024.Powered by Capital Market - Live

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 496.5, up 4.39% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 25182.65. The Sensex is at 82274.5, down 0.09%. Laurus Labs Ltd has risen around 17.43% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 8.25% in last one month and is currently quoting at 23184.4, up 0.68% on the day. The volume in the stock stood at 77.3 lakh shares today, compared to the daily average of 21.43 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 497.85, up 4.08% on the day. Laurus Labs Ltd is up 21.9% in last one year as compared to a 28.41% spurt in NIFTY and a 52.01% spurt in the Nifty Pharma index.The PE of the stock is 107.07 based on TTM earnings ending June 24.Powered by Capital Market - Live